Navigating Biomarkers and Shared Decision-Making in Prodromal Parkinson's Disease

This chapter explores the challenges of using biomarkers for assessing prodromal Parkinson's Disease, especially in those with familial links to the condition. It underscores the significance of collaborative decision-making between patients and clinicians, while advocating for improved awareness of prodromal symptoms and the evolving role of biomarker technology.